Highlights
• The Drug Controller General of India (DCGI) has approved use of the anti-viral drug Remdesivir
• Remdesivir is permitted for ‘restricted emergency use' on severely ill coronavirus patients
• At present, India’s top four pharmaceutical companies have submitted application for manufacturing and sale of Remdesivir in India
With more 3.32 lakh cases of corona....
Tags : Remdesivir, Gilead Sciences, Remdesivir India, DCGI, Government of India, coronavirus,
comments (0)